Royal Bank of Canada’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-80
| Closed | -$1K | – | 7285 |
|
2022
Q4 | $1K | Sell |
80
-1,049
| -93% | -$13.1K | ﹤0.01% | 6675 |
|
2022
Q3 | $10K | Buy |
1,129
+329
| +41% | +$2.91K | ﹤0.01% | 5956 |
|
2022
Q2 | $5K | Hold |
800
| – | – | ﹤0.01% | 6227 |
|
2022
Q1 | $4K | Hold |
800
| – | – | ﹤0.01% | 6874 |
|
2021
Q4 | $4K | Hold |
800
| – | – | ﹤0.01% | 6773 |
|
2021
Q3 | $5K | Sell |
800
-2,876
| -78% | -$18K | ﹤0.01% | 6650 |
|
2021
Q2 | $24K | Buy |
3,676
+1,006
| +38% | +$6.57K | ﹤0.01% | 5990 |
|
2021
Q1 | $20K | Sell |
2,670
-873
| -25% | -$6.54K | ﹤0.01% | 5937 |
|
2020
Q4 | $20K | Buy |
3,543
+2,735
| +338% | +$15.4K | ﹤0.01% | 5528 |
|
2020
Q3 | $5K | Buy |
808
+8
| +1% | +$50 | ﹤0.01% | 5664 |
|
2020
Q2 | $4K | Hold |
800
| – | – | ﹤0.01% | 5667 |
|
2020
Q1 | $3K | Hold |
800
| – | – | ﹤0.01% | 5753 |
|
2019
Q4 | $5K | Hold |
800
| – | – | ﹤0.01% | 5789 |
|
2019
Q3 | $7K | Sell |
800
-270
| -25% | -$2.36K | ﹤0.01% | 5295 |
|
2019
Q2 | $7K | Buy |
1,070
+270
| +34% | +$1.77K | ﹤0.01% | 5313 |
|
2019
Q1 | $7K | Sell |
800
-115
| -13% | -$1.01K | ﹤0.01% | 5237 |
|
2018
Q4 | $15K | Sell |
915
-120
| -12% | -$1.97K | ﹤0.01% | 4965 |
|
2018
Q3 | $34K | Buy |
1,035
+235
| +29% | +$7.72K | ﹤0.01% | 4821 |
|
2018
Q2 | $18K | Buy |
+800
| New | +$18K | ﹤0.01% | 5011 |
|
2015
Q4 | – | Sell |
-24
| Closed | – | – | 6113 |
|
2015
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 6181 |
|
2015
Q2 | $0 | Buy |
+24
| New | – | ﹤0.01% | 6203 |
|
2013
Q4 | – | Sell |
-2,220
| Closed | -$45K | – | 5534 |
|
2013
Q3 | $45K | Sell |
2,220
-1,280
| -37% | -$25.9K | ﹤0.01% | 4300 |
|
2013
Q2 | $88K | Buy |
+3,500
| New | +$88K | ﹤0.01% | 3809 |
|